Hong Kong · India · Singapore · China · Fortune Technology
In February, IHH shipped a program called IHH Catalyst, which brings together healthcare entrepreneurs
Compiled by KHAO Editorial — aggregated from 1 source. See llms.txt for citation guidance.
◌ Single Source
IHH will soon bring the initiative to North Asia, led by Gleneagles Hong Kong and Parkway Shanghai.
Key facts
- Today, IHH Healthcare has expanded to 89 hospitals across 10 countries; the firm, with 2025 revenue of approximately $6 billion, ranks No. 58 on Fortune ’s Southeast Asia 500 list
- In 2019, IHH led a $20 million Series A funding round for Singapore-based genomic medicine firm Lucence, which makes ultra-sensitive blood tests called liquid biopsies that can detect over ten types
- One in four people in the region will be older than 65 by 2050, according to the Asian Development Bank
- IHH shares are up by more than 20% over the past 12 months
Summary
So says Prem Kumar Nair, CEO of Asia’s largest private health group, IHH Healthcare, as he grapples with an Asia that’s wealthier, longer-lived, and far more willing to spend money on the finer things in life. Asia is getting older. IHH is stepping in with “Healthspan”, a new preventive health and longevity program launched in July. “For many people, longevity means aesthetics: coloring your hair, and taking a whole lot of vitamins and supplements. Take sarcopenia, the age-related loss of muscle mass.